The experimental therapy M102 slowed disease progression in preclinical experiments done in mouse and cell models of ALS, a ...

When symptoms of amyotrophic lateral sclerosis (ALS), such as weakness and a loss of muscle mass, start in the limbs, doctors refer to the condition as limb onset ALS. ALS is a progressive condition ...

SPG302 was well tolerated in a trial, with preliminary data supporting the idea the therapy might slow ALS progression.

Amyotrophic lateral sclerosis (ALS) is a condition that causes the degeneration of the nerve cells in the nervous system, affecting certain neurons in the spinal cord. ALS is a fatal disease that ...

SOUTH SAN FRANCISCO & BARCELONA, Spain--(BUSINESS WIRE)--Verge Genomics, a leading clinical-stage biotechnology company, and Ferrer, an international B Corp pharmaceutical company with an increasing ...